Financial statements Na Rzecz Zwalczania Chorób Zakaźnych, Immunologicznych Oraz Wspierania Intensywnej Terapii
Balance sheet data of NA RZECZ ZWALCZANIA CHORÓB ZAKAŹNYCH, IMMUNOLOGICZNYCH ORAZ WSPIERANIA INTENSYWNEJ TERAPII
|
Year
|
2020
|
2021
|
|---|---|---|
| Total assets | 120 204,26 | 911 696,18 |
| A. Fixed assets | - | 367 733,32 |
| B. Current assets | 120 204,26 | 543 962,86 |
| C. Share capital contributions (basic funds) | - | 0,00 |
| D. Own shares (stocks) | - | - |
| Total liabilities | 120 204,26 | 911 696,18 |
| A. Equity | 694 304,12 | -89 521,71 |
| B. Liabilities and provisions for liabilities | 14 799,29 | 1 001 217,89 |
| I. Long-term liabilities | - | 0,00 |
| II. Short-term liabilities | 14 799,29 | 27 517,57 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.